Non-segmental Vitiligo Clinical Trials
33 clinical trials for Non-segmental Vitiligo across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo — RECRUITING · PHASE2
- Study of D-2570 in Subjects With Non-Segmental Vitiligo — RECRUITING · PHASE2
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo — RECRUITING · PHASE2
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients — RECRUITING · PHASE2
- B7981041: A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTICENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
- A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo — RECRUITING · PHASE2
- A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa — RECRUITING
- Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo — RECRUITING · PHASE2
- Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients — RECRUITING · PHASE4
- An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV) — RECRUITING · PHASE2
- ICP-332 in Subjects With Non-segmental Vitiligo — RECRUITING · PHASE2
- A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy — TERMINATED · PHASE3
- A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) — TERMINATED · PHASE2
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study — NOT_YET_RECRUITING
- A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo — NOT_YET_RECRUITING · PHASE2
- A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants with Nonsegmental Vitiligo. — TERMINATED · PHASE2
- Evaluation of the Efficacy and Safety of LW402 Tablets in Patients With Non-Segmental Vitiligo — NOT_YET_RECRUITING · PHASE2
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. — TERMINATED · PHASE2
- Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China — COMPLETED
- Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) — COMPLETED · PHASE3
- Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) — COMPLETED · PHASE3
- A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants with Non-Segmental Vitiligo. — OTHER · PHASE2
- Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo — COMPLETED · PHASE2
- A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental vitiligo — OTHER · PHASE2
- Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo — COMPLETED · PHASE2
- Transplantation of Autologous Non-Cultured Extracted Hair Follicle Outer Root Sheath Cell Suspension and Mini Punch Graft for Stable Non-Segmental Vitiligo Lesions — COMPLETED · NA
- A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients — OTHER · PHASE2
- The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo — COMPLETED · PHASE3
- ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO — OTHER · NA
- Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation — OTHER · PHASE4
- The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo — COMPLETED · PHASE1
- ReNovaCell in Non-segmental Vitiligo — TERMINATED · NA
- Punchgrafting Techniques for Vitiligo — OTHER · PHASE4
Refine this search